Low-grade B-cell lymphomas of long bones are, to our knowledge, unreported in young people. The few cases of long bone lymphomas reported in pediatric population were of diffuse large B-cell lymphoma type. Additionally, chronic sclerosing osteomyelitis is a rare recurring bone inflammation with prominent fibrosis with unknown etiology and unknown relationship to chronic recurrent multifocal osteomyelitis of children. We report a case of a 12-year-old boy with a recent history of Lyme disease and currently on treatment who presented with intermittent knee swelling with multifocal bone lesions of bilateral lower extremities that was subsequently diagnosed with the above rare disease. The patient underwent tibial bone biopsy revealing prominent fibrosis and B-cell lymphocytosis. The B-cells labeled with immunohistochemical stains CD20 and CD79a, and were negative with CD10, CD34, and TdT. Molecular studies unveiled clonal B-cells. The atypical B-cell proliferation appears to evolve to low-grade B-cell lymphoma. Marginal zone lymphoma is an indolent disease known to occur in adult patients with established association with bacterial infections such as Helicobacter pylori in peptic ulcer disease. Although the implications of B-cell clonality in this case are unclear, B-cell proliferation associated with Helicobacter pylori is responsive to antibiotic therapy. Therefore, eradication of infection may render resolution of clonal B-cell hyperplasia. Furthermore, the bone biopsy showed very prominent fibrosis consistent with chronic sclerosing osteomyelitis. Rare reported cases of multisite osteomyelitis have been attributed to Borrelia burgdorferi, the causative organism of Lyme disease. Several Lyme disease cases demonstrate B-cell pleocytosis in the cerebrospinal fluid. Currently, there is no clear documented association of Lyme disease with sclerosing osteomyelitis and clonal B-cell proliferation or lymphoma. Hence, reporting of this peculiar case is necessary to gain an understanding of this uncommon occurrence. Introduction: Despite the steady improvement in outlook for children with acute lymphoblastic leukemia (ALL), 20%-25% of patients still experience relapse. Isolated extramedullary relapse of acute leukemia is a rare occurrence. Most common sites for relapse are central nervous system and testes; however, unusual other sites have been reported. We report an unusual pediatric presentation of an extramedullary relapse of acute lymphoblastic leukemia. Methods: A 13-year-old boy with a known history of B acute lymphoblastic leukemia status post stem cell transplantation was referred to our hospital, complaining of cardiac arrest secondary to third-degree complete atrioventricular dissociation. He had undergone emergent implantation of transvenous pacing leads and had Breinholt myocardial biopsy. Results: Microscopic examination of the myocardial biopsy revealed heavy infiltration of myocardium and pericardium by leukemic cells with focal fibrotic scar. Immunohistochemical staining of paraffin embedded tissue showed strong positivity of the leukemic cells for CD19, PAX5, CD79a, and CD10, and focal positivity for TdT, while CD3 was positive in few scattered T-cells. Epstein-Barr virus-encoded RNA (EBER) in situ hybridization was also performed and revealed a negative result. CT-guided bone marrow aspirate and core biopsy were performed and revealed no leukemic cells involving the bone marrow. A diagnosis of relapsing B acute lymphoblastic leukemia was rendered. Discussion and Conclusion: Leukemic relapses are more devastating to patients and families than the original diagnosis. Most cases of cardiac leukemic relapses were reported in postmortem examinations. However leukemic myocardial involvement at antemortem examination is a rare finding. Current therapy protocols for isolated extramedullary relapse use intensive re-induction systemic chemotherapy in addition to site-specific therapy. Although rare, the present case is noteworthy in highlighting the unusual pediatric third-degree heart block presentation of relapse B-acute lymphoblastic leukemia.
